Download PDF
Am J Perinatol
DOI: 10.1055/a-2622-3839
Original Article

Maternal Area of Residence and Outcomes for Mother–Infant Dyads with Perinatal Opioid Exposure

Adrienne Pahl 
1   Department of Pediatrics, Robert Larner, M.D., College of Medicine at the University of Vermont, Burlington, Vermont
,
Zhuopei Hu
2   Department of Biostatistics, University of Arkansas for Medical Sciences College of Medicine, Little Rock, Arkansas
,
Leslie W. Young
1   Department of Pediatrics, Robert Larner, M.D., College of Medicine at the University of Vermont, Burlington, Vermont
,
Kara Wong Ramsey
3   Department of Pediatrics, Kapiolani Medical Center for Women and Children, Honolulu, Hawaii
,
Bonny L. Whalen
4   Pediatric Hospital Medicine, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
,
Akshatha Akshatha
3   Department of Pediatrics, Kapiolani Medical Center for Women and Children, Honolulu, Hawaii
,
Kristen L. Benninger
5   Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio
,
Camille M. Fung 
6   Department of Pediatric Neonatology, University of Utah School of Medicine, Salt Lake City, Utah
,
Meghan P. Howell
7   Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana
,
Sofia Markee
8   Department of Pediatrics, University of New Mexico, Albuquerque, New Mexico
,
Abhik Das 
9   Social, Statistical, and Environmental Sciences Unit, RTI International, Research Triangle Park, North Carolina
,
Margaret M. Crawford
9   Social, Statistical, and Environmental Sciences Unit, RTI International, Research Triangle Park, North Carolina
,
Lillian Trochinski
9   Social, Statistical, and Environmental Sciences Unit, RTI International, Research Triangle Park, North Carolina
,
Rachel G. Greenberg 
10   Department of Pediatrics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina
,
Brian Smith
10   Department of Pediatrics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina
,
Songthip T. Ounpraseuth
2   Department of Biostatistics, University of Arkansas for Medical Sciences College of Medicine, Little Rock, Arkansas
,
Stephanie L. Merhar
11   Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
,
Lori A. Devlin
12   Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky
,
Kathryn Dee L. MacMillan 
4   Pediatric Hospital Medicine, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
,
for the Eunice Kennedy Shriver NICHD Neonatal Research Network the NIH ECHO Program IDeA States Pediatric Clinical Trials Network› Author Affiliations
Funding This work was funded by the U.S. Department of Health and Human Services, National Institutes of Health, and Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant nos.: 2UG10D024947-03, 3U2COD023375-06S1, 3U2COD023375-07S2, U10 HD053089, U24 OD024957, UG1 HD27853, UG1 HD36790, UG1 HD68278, UG1 HD87226, UG1 OD024954, UG1 OD024955, UG1 OD024959, UL1 TR105, and UL1 TR77).
› Further Information
Also available at
   Permissions and Reprints

Abstract

Objective

Determine the relationship between maternal Social Deprivation Index (SDI), a composite measure of area-level deprivation, and maternal characteristics and infant outcomes for mother–infant dyads with perinatal opioid exposure.

Study Design

Post hoc secondary analysis of 1,298 mother–infant dyads in the ESC-NOW study, a multicenter, stepped-wedge cluster-randomized controlled trial (2020–2022) conducted at 26 U.S. study hospitals. The 2016 American Community Survey was used to develop SDI scores based on the maternal zip code of residence at the time of delivery. Outcomes evaluated included receipt of pharmacologic treatment for neonatal opioid withdrawal syndrome (PT), receipt of breastmilk during hospital stay, direct breastfeeding at discharge, discharge disposition, and length of stay for infants who received PT (length of hospital stay, LOS).

Results

The median SDI score was 62 on a scale of 100. The high SDI group, with a score above the SDI median and more social deprivation, was less likely to receive adequate prenatal care or medication for opioid use disorder and more likely to be Black and/or Hispanic. The mean proportion of infants in the high SDI group was 6.2% points (relative risk [RR]: 0.89; 95% confidence interval [CI]: 0.80, 0.98) less likely to receive breastmilk during the newborn hospitalization and 7.3% points (RR: 0.91; 95% CI: 0.87, 0.96) less likely to be discharged home with a biological parent. There was no difference between the high and low SDI groups in receipt of PT, direct breastfeeding at discharge, or LOS.

Conclusion

Mothers from high SDI communities with opioid exposure during pregnancy were less likely to receive the established standard of care and more likely to be Black and/or Hispanic. Infants born to these mothers were less likely to receive breastmilk and/or to be discharged home with a biological parent. Targeting interventions to mitigate the impact of social deprivation in high SDI communities may improve outcomes for opioid-exposed infants and their mothers.

Key Points

  • Living in an area with high social deprivation was associated with differences in health outcomes.

  • Mothers were more likely to be Black and/or Hispanic.

  • Mothers were less likely to receive the standard of care during pregnancy.

  • Infants were less likely to receive breastmilk and/or be discharged home with a biological parent.

  • Interventions designed to address community social deprivation may improve outcomes.

Keywords

social deprivation - neonatal Abstinence syndrome - opioid - perinatal care - neonatal opioid withdrawal syndrome - residence characteristics - sociodemographic factors

Author's Contributions

Z.H. and S.T.O. had full access to all of the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design, acquisition, analysis, and interpretation of data were done by A.P., Z.H., L.W.Y., S.T.O., S.L.M., L.A.D. and K.D.L.M. Drafting of the manuscript was done by A.P., Z.H., L.W.Y., K.W.R., B.L.W., A.A, K.L.B., C.M.F., M.P.H., S.M., A.D., M.M.C., L.T., R.G.G., B.S., S.T.O., S.L.M., L.A.D. and K.D.L.M.




Publication History

Received: 08 May 2025

Accepted: 26 May 2025

Accepted Manuscript online:
28 May 2025

Article published online:
16 June 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Sullivan BA, Doshi A, Chernyavskiy P. et al. Neighborhood deprivation and association with neonatal intensive care unit mortality and morbidity for extremely premature infants. JAMA Netw Open 2023; 6 (05) e2311761
    Search in Google Scholar
  • 2 Vos AA, Posthumus AG, Bonsel GJ, Steegers EAP, Denktaş S. Deprived neighborhoods and adverse perinatal outcome: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2014; 93 (08) 727-740
    Search in Google Scholar
  • 3 Weightman AL, Morgan HE, Shepherd MA, Kitcher H, Roberts C, Dunstan FD. Social inequality and infant health in the UK: systematic review and meta-analyses. BMJ Open 2012; 2 (03) e000964
    Search in Google Scholar
  • 4 Holt-Lunstad J. Social connection as a public health issue: the evidence and a systemic framework for prioritizing the “social” in social determinants of health. Annu Rev Public Health 2022; 43 (01) 193-213
    Search in Google Scholar
  • 5 Blount AJ, Adams CR, Anderson-Berry AL, Hanson C, Schneider K, Pendyala G. Biopsychosocial factors during the perinatal period: risks, preventative factors, and implications for healthcare professionals. Int J Environ Res Public Health 2021; 18 (15) 8206
    Search in Google Scholar
  • 6 Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017. JAMA 2021; 325 (02) 146-155
    Search in Google Scholar
  • 7 Conner KL, Meadows AL, Delcher C, Talbert JC. Neonatal abstinence syndrome and childhood mental health conditions, 2009-2015: commercial versus medicaid populations. Psychiatr Serv 2020; 71 (02) 184-187
    Search in Google Scholar
  • 8 Umer A, Lilly C, Hamilton C. et al. Disparities in neonatal abstinence syndrome and health insurance status: a statewide study using non-claims real-time surveillance data. Paediatr Perinat Epidemiol 2021; 35 (03) 330-338
    Search in Google Scholar
  • 9 Decker CM, Mahar M, Howells CL, Ma ZQ, Goetz CT, Watkins SM. Demographics, birth parameters, and social determinants of health among opioid-exposed mother-infant dyads affected by neonatal abstinence syndrome in Pennsylvania, 2018-2019. Matern Child Health J 2023; 27 (Suppl. 01) 34-43
    Search in Google Scholar
  • 10 Dookeran KA, Feffer MG, Quigley KM, Troller PE, Christmon CA, Khan JY. Disparity in neonatal abstinence syndrome by race/ethnicity, socioeconomic status, and geography, in neonates ≥ 35 weeks gestational age. PLoS One 2023; 18 (04) e0284040
    Search in Google Scholar
  • 11 Patrick SW, Faherty LJ, Dick AW, Scott TA, Dudley J, Stein BD. Association among county-level economic factors, clinician supply, metropolitan or rural location, and neonatal abstinence syndrome. JAMA 2019; 321 (04) 385-393
    Search in Google Scholar
  • 12 Loch SF, Stein BD, Ghertner R. et al. Neonatal opioid withdrawal syndrome is associated with infant foster care entry at the county level. Health Aff (Millwood) 2021; 40 (11) 1776-1783
    Search in Google Scholar
  • 13 Syvertsen JL, Toneff H, Howard H, Spadola C, Madden D, Clapp J. Conceptualizing stigma in contexts of pregnancy and opioid misuse: a qualitative study with women and healthcare providers in Ohio. Drug Alcohol Depend 2021; 222: 108677
    Search in Google Scholar
  • 14 Schiff DM, Work EC, Muftu S. et al. “You have to take this medication, but then you get punished for taking it:” lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period. J Subst Abuse Treat 2022; 139: 108765
    Search in Google Scholar
  • 15 Frazer Z, McConnell K, Jansson LM. Treatment for substance use disorders in pregnant women: motivators and barriers. Drug Alcohol Depend 2019; 205: 107652
    Search in Google Scholar
  • 16 Barnett ER, Knight E, Herman RJ, Amarakaran K, Jankowski MK. Difficult binds: a systematic review of facilitators and barriers to treatment among mothers with substance use disorders. J Subst Abuse Treat 2021; 126: 108341
    Search in Google Scholar
  • 17 Leiner C, Cody T, Mullins N, Ramage M, Ostrach BMM. “The elephant in the room;” a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia. BMC Pregnancy Childbirth 2021; 21 (01) 143
    Search in Google Scholar
  • 18 Burgess A, Bauer E, Gallagher S. et al. Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: a qualitative analysis. J Subst Abuse Treat 2021; 130: 108488
    Search in Google Scholar
  • 19 Kulesza M, Matsuda M, Ramirez JJ, Werntz AJ, Teachman BA, Lindgren KP. Towards greater understanding of addiction stigma: intersectionality with race/ethnicity and gender. Drug Alcohol Depend 2016; 169: 85-91
    Search in Google Scholar
  • 20 Miller PK, Cuthbertson CA, Loveridge S. Social status influence on stigma towards mental illness and substance use disorder in the United States. Community Ment Health J 2022; 58 (02) 249-260
    Search in Google Scholar
  • 21 Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev 2005; 24 (02) 143-155
    Search in Google Scholar
  • 22 Schiff DM, Li WZM, Work EC. et al. Multiple marginalized identities: a qualitative exploration of intersectional perinatal experiences of birthing people of color with substance use disorder in Massachusetts. J Subst Use Addict Treat 2024; 163: 209346
    Search in Google Scholar
  • 23 Young LW, Ounpraseuth ST, Merhar SL. et al; ACT NOW Collaborative. Eat, sleep, console approach or usual care for neonatal opioid withdrawal. N Engl J Med 2023; 388 (25) 2326-2337
    Search in Google Scholar
  • 24 Vesoulis ZA, Lust CE, Cohlan BA, Liao SM, Mathur AM. Poverty and excess length of hospital stay in neonatal opioid withdrawal syndrome. J Addict Med 2020; 14 (02) 113-118
    Search in Google Scholar
  • 25 Rose-Jacobs R, Trevino-Talbot M, Lloyd-Travaglini C. et al. Could prenatal food insecurity influence neonatal abstinence syndrome severity?. Addiction 2019; 114 (02) 337-343
    Search in Google Scholar
  • 26 Robert Graham Center - Policy Studies in Family Medicine & Primary Care. Social deprivation index (SDI). Published online September 8, 2023 at: https://www.graham-center.org/rgc/maps-data-tools/sdi/social-deprivation-index.html
  • 27 Babatunde OA, Zahnd WE, Eberth JM. et al. Association between neighborhood social deprivation and stage at diagnosis among breast cancer patients in South Carolina. Int J Environ Res Public Health 2021; 18 (22) 11824
    Search in Google Scholar
  • 28 Goyal P, Schenck E, Wu Y. et al. Influence of social deprivation index on in-hospital outcomes of COVID-19. Sci Rep 2023; 13 (01) 1746
    Search in Google Scholar
  • 29 Qian ZJ, Rehkopf DH. Association between social disadvantage and Otitis media treatment in US children with commercial insurance. JAMA Otolaryngol Head Neck Surg 2022; 149 (01) 7-14
    Search in Google Scholar
  • 30 Lucas JA, Marino M, Fankhauser K. et al. Role of social deprivation on asthma care quality among a cohort of children in US community health centres. BMJ Open 2021; 11 (06) e045131
    Search in Google Scholar
  • 31 Xi W, Banerjee S, Olfson M, Alexopoulos GS, Xiao Y, Pathak J. Effects of social deprivation on risk factors for suicidal ideation and suicide attempts in commercially insured US youth and adults. Sci Rep 2023; 13 (01) 4151
    Search in Google Scholar
  • 32 Topmiller M, McCann J, Rankin J, Hoang H, Bolton J, Sripipatana A. Exploring the association of social determinants of health and clinical quality measures and performance in HRSA-funded health centres. Fam Med Community Health 2021; 9 (03) e000853
    Search in Google Scholar
  • 33 Lucas JA, Marino M, Giebultowicz S. et al. Mobility and social deprivation on primary care utilisation among paediatric patients with asthma. Fam Med Community Health 2021; 9 (03) e001085
    Search in Google Scholar
  • 34 Wachman EM, Schiff DM, Silverstein M. Neonatal abstinence syndrome: advances in diagnosis and treatment. JAMA 2018; 319 (13) 1362-1374
    Search in Google Scholar
  • 35 Joudrey PJ, Kolak M, Lin Q, Paykin S, Anguiano Jr V, Wang EA. Assessment of community-level vulnerability and access to medications for opioid use disorder. JAMA Netw Open 2022; 5 (04) e227028
    Search in Google Scholar
  • 36 Joshi C, Ho Chui KK, Skeer MR, Stopka TJ. Spatial and nonspatial factors associated with access to medication for opioid use disorder among pregnant women in Massachusetts. Subst Use Misuse 2022; 57 (13) 1904-1917
    Search in Google Scholar
  • 37 Xu KY, Schiff DM, Jones HE. et al. Racial and ethnic inequities in buprenorphine and methadone utilization among reproductive-age women with opioid use disorder: an analysis of multi-state medicaid claims in the USA. J Gen Intern Med 2023; 38 (16) 3499-3508
    Search in Google Scholar
  • 38 Green TL. Unpacking racial/ethnic disparities in prenatal care use: the role of individual-, household-, and area-level characteristics. J Womens Health (Larchmt) 2018; 27 (09) 1124-1134
    Search in Google Scholar
  • 39 Shrider EA, Creamer J. Poverty in the United States: 2022. US Census Bureau; 2023. . Accessed August 25, 2024 at: https://www.census.gov/content/dam/Census/library/publications/2023/demo/p60-280.pdf
    Search in Google Scholar
  • 40 Kunins HV, Bellin E, Chazotte C, Du E, Arnsten JH. The effect of race on provider decisions to test for illicit drug use in the peripartum setting. J Womens Health (Larchmt) 2007; 16 (02) 245-255
    Search in Google Scholar
  • 41 Roberts SCM, Nuru-Jeter A. Universal screening for alcohol and drug use and racial disparities in child protective services reporting. J Behav Health Serv Res 2012; 39 (01) 3-16
    Search in Google Scholar
  • 42 Cohen S, Nielsen T, Chou JH. et al. Disparities in maternal-infant drug testing, social work assessment, and custody at 5 hospitals. Acad Pediatr 2023; 23 (06) 1268-1275
    Search in Google Scholar
  • 43 Schoneich S, Plegue M, Waidley V. et al. Incidence of newborn drug testing and variations by birthing parent race and ethnicity before and after recreational cannabis legalization. JAMA Netw Open 2023; 6 (03) e232058
    Search in Google Scholar
  • 44 Karvonen KL, McKenzie-Sampson S, Baer RJ. et al. Structural racism is associated with adverse postnatal outcomes among Black preterm infants. Pediatr Res 2023; 94 (01) 371-377
    Search in Google Scholar
  • 45 Sarathy L, Chou JH, Lerou PH. et al. Limited utility of toxicology testing at delivery for perinatal cannabis use. Hosp Pediatr 2023; 13 (04) 317-325
    Search in Google Scholar
  • 46 Baldwin H, Biehal N, Allgar V, Cusworth L, Pickett K. Antenatal risk factors for child maltreatment: linkage of data from a birth cohort study to child welfare records. Child Abuse Negl 2020; 107: 104605
    Search in Google Scholar
  • 47 Yourkavitch J, Kane JB, Miles G. Neighborhood disadvantage and neighborhood affluence: associations with breastfeeding practices in urban areas. Matern Child Health J 2018; 22 (04) 546-555
    Search in Google Scholar
  • 48 Andermann A. CLEAR Collaboration. Taking action on the social determinants of health in clinical practice: a framework for health professionals. CMAJ 2016; 188 (17-18): E474-E483
    Search in Google Scholar
  • 49 Whitman A, De Lew N, Chappel A, Aysola V, Zuckerman R. Addressing Social Determinants of Health: Examples of Successful Evidence-Based Strategies and Current Federal Efforts. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation; 2022. . Accessed February 1, 2025 at: https://collections-nlm-nih-gov.accesdistant.sorbonne-universite.fr/catalog/nlm:nlmuid-9918589885806676-pdf
    Search in Google Scholar
  • 50 Schiff DM, Partridge S, Gummadi NH. et al. Caring for families impacted by opioid use: a qualitative analysis of integrated program designs. Acad Pediatr 2022; 22 (01) 125-136
    Search in Google Scholar
  • 51 Goodman DJ, Saunders EC, Frew JR. et al. Integrated vs nonintegrated treatment for perinatal opioid use disorder: retrospective cohort study. Am J Obstet Gynecol MFM 2022; 4 (01) 100489
    Search in Google Scholar
  • 52 Whalen BL, Holmes AV, Blythe S. Models of care for neonatal abstinence syndrome: what works?. Semin Fetal Neonatal Med 2019; 24 (02) 121-132
    Search in Google Scholar
  • 53 Townsel C, Irani S, Buis C. et al. Partnering for the future clinic: a multidisciplinary perinatal substance use program. Gen Hosp Psychiatry 2023; 85: 220-228
    Search in Google Scholar
  • 54 Stulac S, Bair-Merritt M, Wachman EM. et al. Children and families of the opioid epidemic: under the radar. Curr Probl Pediatr Adolesc Health Care 2019; 49 (08) 100637
    Search in Google Scholar
  • 55 Mercer J. Examining circle of security: a review of research and theory. Res Soc Work Pract 2015; 25 (03) 382-392
    Search in Google Scholar
  • 56 Horton E, Murray C. A quantitative exploratory evaluation of the circle of security-parenting program with mothers in residential substance-abuse treatment. Infant Ment Health J 2015; 36 (03) 320-336
    Search in Google Scholar
  • 57 Suchman NE, DeCoste C, Borelli JL, McMahon TJ. Does improvement in maternal attachment representations predict greater maternal sensitivity, child attachment security and lower rates of relapse to substance use? A second test of mothering from the inside out treatment mechanisms. J Subst Abuse Treat 2018; 85: 21-30
    Search in Google Scholar
  • 58 Bosk EA, Paris R, Hanson KE, Ruisard D, Suchman NE. Innovations in child welfare interventions for caregivers with substance use disorders and their children. Child Youth Serv Rev 2019; 101: 99-112
    Search in Google Scholar
  • 59 Deutsch SA, Donahue J, Parker T, Hossain J, Loiselle C, De Jong AR. Impact of plans of safe care on prenatally substance exposed infants. J Pediatr 2022; 241: 54-61.e7
    Search in Google Scholar
  • 60 Schmidt CN, Patel D, Alpers BS. et al. Facilitating integrated perinatal care for families affected by substance use. J Addict Med 2023; 17 (01) 1-3
    Search in Google Scholar
  • 61 Keenan-Devlin LS, Hughes-Jones JY, Johnson T, Hirschhorn L, Borders AEB. Implementation of a clinically integrated breastfeeding peer counselor program. J Perinatol 2024; 44 (11) 1584-1590
    Search in Google Scholar
  • 62 Hoy S, Harrison J, Craig A, Lafreniere G. The “calm in the storm”: a scoping review of in-hospital peer support breastfeeding interventions. Divers Res Health J. 2021; 4 (January): 10.28984
    Search in Google Scholar
  • 63 Olding M, Cook A, Austin T, Boyd J. “They went down that road, and they get it”: A qualitative study of peer support worker roles within perinatal substance use programs. J Subst Abuse Treat 2022; 132: 108578
    Search in Google Scholar
  • 64 Blackmore A, Howell B, Romme K. et al. The effectiveness of virtual lactation support: a systematic review and meta-analysis. J Hum Lact 2022; 38 (03) 452-465
    Search in Google Scholar
  • 65 Grubesic TH, Durbin KM. The complex geographies of telelactation and access to community breastfeeding support in the state of Ohio. PLoS One 2020; 15 (11) e0242457
    Search in Google Scholar
  • 66 Harris M, Schiff DM, Saia K, Muftu S, Standish KR, Wachman EM. Academy of breastfeeding medicine clinical protocol #21: breastfeeding in the setting of substance use and substance use disorder (revised 2023). Breastfeed Med 2023; 18 (10) 715-733
    Search in Google Scholar
  • 67 Bensken WP, McGrath BM, Gold R, Cottrell EK. Area-level social determinants of health and individual-level social risks: assessing predictive ability and biases in social risk screening. J Clin Transl Sci 2023; 7 (01) e257
    Search in Google Scholar